SWOG clinical trial number
SWOG-7524

Chemoimmunotherapy in Stages III & IV Ovarian and Endometrial Carcinoma Adriamycin + Cyclophosphamide vs. Adriamycin + Cyclophosphamide + BCG

Closed
Phase
Abbreviated Title
Chemoimmunotherapy in Stages III & IV Ovarian and Endometrial Carcinoma Adriamycin + Cyclophosphamide vs. Adriamycin + Cyclophosphamide + BCG
Activated
01/07/1976
Closed
10/22/1980

Publication Information Expand/Collapse

2009

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

1982

A randomized trial of Doxorubicin and Cyclophosphamide + BCG vs. Doxorubicin and Cyclophosphamide therapy of advanced ovarian cancer.

DS Alberts;NL Mason;R O'Toole;J Neff;R Hilgers;D Carlin;TE Moon In: Immunotherapy of Human Cancer. WD Terry, SA Rosenberg, eds. New York: Elsevier-North Holland, 343-350

1980

Randomized trial of chemotherapy versus chemo- immunotherapy for advanced ovarian carcinoma: A preliminary report of a Southwest Oncology Group study.

DS Alberts;TE Moon Immunotherapy of Cancer: Present Status of Trials in Man, p. 13, April

1979

Randomized study of chemoimmunotherapy for advanced ovarian carcinoma. A preliminary report of a Southwest Oncology Group study.

DS Alberts;TE Moon;RA Stephens;H Wilson;N Oishi;RD Hilgers;R O'Toole;JT Thigpen Cancer Treat Rep 63(2):325-331

Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin cyclophosphamide + BCG: Early report of a Southwest Oncology Group study.

D Alberts;SE Salmon;TE Moon Recent Results in Cancer Research 68:160-165

BCG as an adjuvant to Adriamycin-Cyclophosphamide in the treatment of advanced ovarian carcinoma: Ongoing analysis of a Southwest Oncology Group study.

D Alberts;T Moon;R O'Toole;J Neff;JT Thigpen;J Blessing In: Adjuvant Therapy of Cancer II , pp. 483-494

BCG as an adjuvant to adriamycin - cytoxan for advanced ovarian cancer.

D Alberts International Conference on the Adjuvant Therapy of Cancer #38

1978

Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide + BCG: Early report of a Southwest Oncology Group study.

DS Alberts;SE Salmon;TE Moon Recent Results Cancer Res 68: 160-165

1977

Adjuvant immunotherapy with BCG of advanced ovarian cancer: A preliminary report.

DS Alberts In: Adjuvant Therapy of Cancer, pp. 327-334. Proceedings of the International Conference on the Adjuvant Therapy of Cancer Held in Tucson, Arizona, U.S.A., March 2-5, 1977, Sydney E. Salmon, Stephen Ellis Jones, eds., North-Holland Publishing Company, 1977